>
Organization
Merck KGaA
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Merck KGaA

... Patient recruitment for ongoing first-line renal cell carcinoma (RCC) studies run by Merck/Eisai and Bristol-Myers Squibb/Exelixis have been affected by the approval of BMS' Opdivo ...
... market comprises major providers such as Thermo Fisher Scientific (US), Abcam (UK), Merck KGaA (Germany). The study includes an in-depth competitive analysis of these key ...
... BioLegend, Inc. - Bio-Rad Laboratories, Inc. - Enzo Life Sciences, Inc. - Merck KgaA Read the full report: RESEARCH ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAY) MCP-6082 A ...
... editing under careful consideration of ethical and legal standards. MilliporeSigma's parent company, Merck KGaA, Darmstadt, Germany, has established an independent, externalBioethics Advisory Panelto provide guidance ...
... the food colorants market include BASF, Cargill, Koninklijke DSM N.V., DowDuPont, and Merck. Few of the major customers include Tyson Group, Kerry Foods, Ingredion, PepsiCo, ...
... by Pfizer, Inc., and is part of an alliance between Pfizer and Merck KGaA. Dr. Choueiri reports grants, personal fees and non-financial support from Pfizer, ...
... prognostic risk groups, and show increased time to progression on next-line therapy Merck KGaA, Darmstadt, Germany, which operates its biopharmaceutical business as EMD Serono in ...
... the food colorants market include BASF, Cargill, Koninklijke DSM N.V., DowDuPont, and Merck. Few of the major customers include Tyson Group, Kerry Foods, Ingredion, PepsiCo, ...
... (SAIC), Keryx Biopharmaceuticals (now a subsidiary of Akebia Therapeutics), Thermo Fisher Scientific, Merck KGaA, Merck & Co., Bristol-Myers Squibb, Cambridge Assessment English, Novartis, Incyte, Sanofi ...
... Bristol-Myers Squibb investors have been dreading positive kidney cancer results from archrival Merck for months. And now that they're here, they might do even more ...
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/News/merck-kgaa-o28738
  • https://relationshipscience.com/News/merck-kgaa-o28738
Subscribe now for full coverage on Merck KGaA
Start My Free Trial